[{"data":1,"prerenderedAt":46},["ShallowReactive",2],{"q-nurse-106-1-medical-surgical-057":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-106-1-內外科護理學-057","nurse-106-1-medical-surgical-057",106,1,57,"使用下列那一種肺結核治療藥物不需監測肝功能？",{"A":14,"B":15,"C":16,"D":17},"Ethambutol（EMB）","Isoniazid（INH）","Pyrazinamide（PZA）","Rifampin（RMP）","A",null,[],"本題考點為第一線抗結核藥物的副作用監測差異。抗結核藥中 Isoniazid（INH）、Rifampin（RMP）、Pyrazinamide（PZA）皆具肝毒性，服藥期間須定期監測肝功能;而 Ethambutol（EMB）的主要副作用為視神經炎，須監測視力與辨色力而非肝功能，故不需監測肝功能者為 A。B INH、C PZA、D RMP 三者均會造成肝細胞損傷，皆須追蹤肝功能，故不選。",[23,26,30,34,38,42],{"webId":24,"stem":25,"number":10,"year":9,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",{"webId":27,"stem":28,"number":29,"year":9,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",2,{"webId":31,"stem":32,"number":33,"year":9,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":35,"stem":36,"number":37,"year":9,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":39,"stem":40,"number":41,"year":9,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":43,"stem":44,"number":45,"year":9,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840733815]